Missense mutation (C667F) in murine β-dystroglycan causes embryonic lethality, myopathy and blood-brain barrier destabilization
Article in Disease Models & Mechanisms (April 2024)
The most recent citing publications are shown below. View all 141 publications that cite this research output on Dimensions.
A missense mutation (C667F) in β-dystroglycan results in reduced dystroglycan protein levels leading to myopathy and destabilization of the blood-brain and blood-retinal barrier protein network
Preprint in bioRxiv (November 2023)
Cell Therapy for Muscular Dystrophy
Book chapter (November 2023)